Literature DB >> 24437316

Prevalence and risk factors for HIV infection among men having sex with men in Metro Manila, Philippines.

Louie Mar A Gangcuangco1, Maria Lourdes Tan2, Regina P Berba3.   

Abstract

HIV incidence in the Philippines is increasing at an alarming rate. We conducted this study to understand the factors catalyzing the HIV epidemic among men having sex with men (MSM) in Metro Manila. From November 2009 to January 2010, an HIV testing booth was set up adjacent to bars and restaurants in Metro Manila frequented by MSM at night. Participants aged > or =18 years were interviewed using a structured questionnaire. Rapid HIV antibody screening was performed using SD Bioline HIV 1/2 3.0 (Standard Diagnostics). Of 406 MSM included in the study, the mean age was 26.2 years [standard deviation (SD) 5.4]; 96% believed condoms reduced HIV risk but only 3% reported consistent use. The leading reasons for not using condoms were belief that the partner was HIV negative (34.4%), diminished pleasure (32%), and unavailability (23.4%). The HIV prevalence using the rapid test was 11.8% [95% confidence interval (CI): 8.7- 15.0]. All 40 cases who had a confirmatory Western blot test were positive, of whom 24 were business process outsourcing employees (BPOEs). On multivariate analysis, work as a BPOE [adjusted OR (aOR): 3.37; p=0.001], preference for receptive anal sex (aOR: 5.26; p=0.04), and sex while under the influence of excessive alcohol (aOR: 2.71; p=0.04) were independently associated with HIV. The proportion of BPOEs who consistently use condoms when having insertive anal sex with a stranger was significantly lower compared to non-BPOEs (24.5% versus 38.2%; p=0.02). Urgent interventions are needed to address the HIV epidemic in the Philippines.

Entities:  

Mesh:

Year:  2013        PMID: 24437316

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  6 in total

1.  Medical School Hotline: Dying of AIDS in 2018: Urgent Interventions to Curb the Fastest-Growing HIV Epidemic in the Western Pacific.

Authors:  Louie Mar A Gangcuangco; Satoru Izutsu
Journal:  Hawaii J Med Public Health       Date:  2019-03

2.  Trends and emerging directions in HIV risk and prevention research in the Philippines: A systematic review of the literature.

Authors:  Arjee Restar; Mary Nguyen; Kimberly Nguyen; Alexander Adia; Jennifer Nazareno; Emily Yoshioka; Laufred Hernandez; Don Operario
Journal:  PLoS One       Date:  2018-12-05       Impact factor: 3.240

3.  Characterizing Awareness of Pre-Exposure Prophylaxis for HIV Prevention in Manila and Cebu, Philippines: Web-Based Survey of Filipino Cisgender Men Who Have Sex With Men.

Authors:  Arjee Restar; Anthony Surace; Alexander Adia; William Goedel; Adedotun Ogunbajo; Harry Jin; Alberto Edeza; Laufred Hernandez; Susan Cu-Uvin; Don Operario
Journal:  J Med Internet Res       Date:  2022-01-07       Impact factor: 5.428

4.  Determinants of consistent condom use among Filipino women: Results from the 2017 Philippine National Demographic and Health Survey.

Authors:  Veincent Christian F Pepito; Arianna Maever L Amit; Clinton S Tang; Ryan Gabriel C Molen; Luis Miguel B Co; Neil Andrew Kiamco Aliazas; Sarah J De Los Reyes; Lourdes Bernadette S Tanchanco
Journal:  BMC Public Health       Date:  2022-08-30       Impact factor: 4.135

5.  Structural barriers to HIV prevention among men who have sex with men (MSM) in Vietnam: Diversity, stigma, and healthcare access.

Authors:  Morgan M Philbin; Jennifer S Hirsch; Patrick A Wilson; An Thanh Ly; Le Minh Giang; Richard G Parker
Journal:  PLoS One       Date:  2018-04-03       Impact factor: 3.240

6.  Differences in HIV risk and healthcare engagement factors in Filipinx transgender women and cisgender men who have sex with men who reported being HIV negative, HIV positive or HIV unknown.

Authors:  Arjee J Restar; Harry Jin; Adedotun Ogunbajo; Alexander Adia; Anthony Surace; Laufred Hernandez; Susan Cu-Uvin; Don Operario
Journal:  J Int AIDS Soc       Date:  2020-08       Impact factor: 5.396

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.